The role of PET for interim response assessment in patients  with Hodgkin’s lymphoma

Jan Zaucha; Iwona Danielewicz; Bogdan Małkowski; Renata Zaucha; Krzysztof Leśniewski-Kmak

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2009
vol. 13

Send email

Copy url:

abstract:

Review paper

The role of PET for interim response assessment in patients with Hodgkin’s lymphoma

Jan Zaucha

,

Iwona Danielewicz

,

Bogdan Małkowski

,

Renata Zaucha

,

Krzysztof Leśniewski-Kmak

Współczesna Onkologia (2009) vol. 13; 4 (161-166)

Online publish date: 2009/09/15

View full text Get citation

18F 2-fluoro-2-deoxyglucose positron emission tomography (FDG-PET) assessment after completion of therapy for lymphomas has been recently incorporated into the clinical guidelines and is also advocated in Poland by the National Health Fund. There is emerging evidence that in patients with Hodgkin’s lymphoma (HL) PET performed early during chemotherapy predicts the therapy response better than post-therapy PET. However, it is not clear which criteria should be adopted for an interim PET assessment because of minimal residual uptake (MRU), which hampers interpretation of PET scans as positive or negative. This brief review summarizes the evidence to date for the use of interim PET assessment in patients with advanced HL both using ABVD and BEACOPPesc chemotherapy. The rationale for performing an observational study in Poland aiming at defining criteria used for interim PET assessment which could be utilized in the future as a basis for early therapeutic modification in routine clinical practice is also discussed.

keywords:

The role of PET for interim response assessment in patients with Hodgkin’s lymphoma

Jan Zaucha , Iwona Danielewicz , Bogdan Małkowski , Renata Zaucha , Krzysztof Leśniewski-Kmak

Hodgkin’s lymphoma, positron emission tomography

Jan Zaucha

,

Iwona Danielewicz

,

Bogdan Małkowski

,

Renata Zaucha

,

Krzysztof Leśniewski-Kmak